Abstracts

PREVALENCE AND CORRELATES OF HPGV INFECTION AMONG PWID WITH HIV INFECTION IN INDIA

Human Pegivirus (HPgV) shares overlapping transmission routes with HIV as it is transmitted through percutaneous and sexual routes. Previous studies have shown that HPgV infection is associated with reduced disease progression among HIV-infected individuals. However, most of these data are from resource-rich settings with non-clade C HIV infection. We estimate the prevalence of HPgV infection…

ERADICATION OF HCV: EFFECTS ON CARDIOVASCULAR RISK AND PRECLINICAL ATHEROSCLEROSIS

We previously showed that eradication of HCV in HIV/HCV-coinfected patients was associated a near-significant increase in the risk of cardiovascular events (Hepatology 2017; 66:344). We compared changes in 10-year Framingham cardiovascular risk (10y-CVR) and changes in noninvasive tests for preclinical atherosclerosis in coinfected patients with and without SVR receiving anti-HCV therapy (anti-HCV Rx). We performed…

HCV AND LIVER DISEASE INCREASE RISK OF NEUROCOGNITIVE IMPAIRMENT IN HIV+ INDIVIDUALS

HCV may be implicated in the pathogenesis of neurocognitive impairment (NCI), but its precise contribution in the setting of the HIV infected (HIV+) population is still controversial. HCV-mediated liver injury may itself contribute to NCI. We investigated the effect of HCV infection and liver function (Lf) on neurocognition. From a prospective, monocenter, observational study conducted…

BLINDED EVALUATION OF ULTRASENSITIVE ASSAYS OF HIV IN PLASMA

A major barrier to developing HIV cure interventions is the lack of validated assays that reliably quantify HIV in plasma below the limit of detection of current clinical assays. We sought to objectively assess the performance characteristics of newer, more sensitive assays to quantify plasma viremia. The HIV Reservoir Assay Validation and Evaluation Network (RAVEN)…